Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
Title | Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage IIB or IIIA Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671) |
---|---|
Disease/Condition | Lung Cancer,Oncology (Medical/Hematologic),Lung Diseases,Carcinoma,Neoplasms |
Eligibility Criteria | Click here for eligibility requirements |
Principal Investigator | Balazs Halmos, MD |
Contact Name | Inuska Rodriguez |
Contact Email | inurodri@montefiore.org |
IRB/Protocol Number | 17-06-456-01 |
Status | Active/Enrolling |
Adult Clinical Trial | Yes |
Pediatric Clinical Trial | No |
Sub-Specialty | Medical and Hematologic Oncology - Lung |